Spyre Therapeutics Inc. (SYRE) Earnings Report - Forecasts and Surprise Ratio

Quarterly Earnings History

SYRE ratio: 40%

100%

SYRE beat 14 of 35 last estimates

Date of next report: Mar 6, 2025

Estimate for Q4 24: $-1.11

Implied change from Q3 24: -18.38%

Implied change from Q4 23: -51.32%

Earnings Period	Date Reported	EPS / Forecast	Surprise
Q3 24	Nov 7, 2024	$-1.36 / $-0.8	$-0.56 / -70%
Q2 24	Aug 7, 2024	$-0.86 / $-0.9	$0.04 / 4.44%
Q1 24	May 9, 2024	$-1.2 / $-0.9	$-0.3 / -33.33%
Q4 23	Feb 29, 2024	$-2.28 / $-0.48	$-1.8 / -375%
Q3 23	Nov 9, 2023	$-3.43 / $-0.44	$-2.99 / -679.55%
Q2 23	Aug 11, 2023	$-41.5 / $-4.5	$-37 / -822.22%
Q1 23	May 11, 2023	$-5 / $-4.75	$-0.25 / -5.26%
Q4 22	Mar 2, 2023	$-4.5 / $-5	$0.5 / 10%

Data Vendor: Xignite Logo